BMRN
BioMarin Pharmaceutical Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +4.1% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 1.42M | $84.45M | n/a | −2 |
| Q2 2026 | 135 | +4 | 146.70M | $8.39B | +11 | −8 |
| Q1 2026 | 135 | -4 | 142.18M | $8.03B | +5 | −10 |
| Q4 2025 | 138 | +3 | 154.93M | $9.20B | +4 | n/a |
| Q3 2025 | 23 | -1 | 108.93M | $5.90B | n/a | −2 |
| Q2 2025 | 22 | -2 | 113.78M | $6.25B | n/a | −2 |
| Q1 2025 | 21 | 0 | 70.58M | $4.99B | +1 | −1 |
| Q4 2024 | 21 | +1 | 67.83M | $4.46B | +1 | n/a |
| Q3 2024 | 19 | 0 | 57.19M | $4.02B | +2 | −2 |
| Q2 2024 | 19 | n/a | 53.80M | $4.43B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 17.77M | -2.3% | $1.26B | 1.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Dodge & Cox ✦ | 14.96M | +1.4% | $1.06B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 3 | Viking Global Investors ✦ | 10.80M | +2.8% | $763.46M | 2.4% | ▲ Add | 4 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passief) | 8.46M | -7.1% | $598.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Elliott Investment Management ✦ | 3.50M | 0.0% | $247.44M | 2.3% | Held | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 3.43M | +4.3% | $242.02M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | Norges Bank ✦ (passief) | 3.31M | -7.3% | $233.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 2.93M | +127.9% | $203.99M | 0.2% | ▲ Add | 4 | SEC ↗ ×7 |
| 9 | Citadel Advisors ✦ | 1.60M | +311.5% | $112.75M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 10 | Renaissance Technologies ✦ | 895.77K | +105.5% | $63.32M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 759.39K | +226.2% | $53.68M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | Millennium Management ✦ | 675.27K | +65.4% | $47.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 545.77K | +98.1% | $38.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 395.75K | +48.5% | $27.98M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 218.07K | Nieuw | $15.42M | 0.0% | New | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 132.35K | -77.7% | $9.36M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 17 | Bridgewater Associates ✦ | 123.66K | -59.1% | $8.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 47.47K | +304.5% | $3.36M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Marshall Wace ✦ | 14.34K | -97.9% | $1.01M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 13.57K | -2.8% | $959,538 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | GAMCO Investors ✦ | 8.29K | -17.4% | $586,020 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Arrowstreet Capital | $15.42M | 0.0% |
Verlaten
| Wellington Management | $490,412 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 549 houders, 183.01M aandelen, $10.09B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 17.56K aand · $1.16M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie